Taken together, the above findings verify the prominent role of LSD1 in promoting stemness and chemoresistance in HCC-CSCs and highlight the promising therapeutic response upon its pharmacological inhibition (Figure 2). This evidence concerns the gene KDM1A and hepatocellular carcinoma.